Opaleye Management Inc. Ptc Therapeutics, Inc. Transaction History

Opaleye Management Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$32.37 - $59.36 $6.18 Million - $11.3 Million	-191,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$32.22 - $50.07 $32,220 - $50,070	1,000 Added 0.53%	191,000 $9.17 Million
Q3 2019 Nov 14, 2019	SELL	$33.82 - $48.17 $1.23 Million - $1.75 Million	-36,388 Reduced 16.07%	190,000 $6.43 Million
Q2 2019 Aug 14, 2019	BUY	$35.42 - $45.0 $445,866 - $566,460	12,588 Added 5.89%	226,388 $10.2 Million
Q1 2019 May 15, 2019	BUY	$28.09 - $39.49 $668,542 - $939,862	23,800 Added 12.53%	213,800 $8.05 Million
Q4 2018 Feb 14, 2019	BUY	$29.83 - $46.51 $298,300 - $465,100	10,000 Added 5.56%	190,000 $6.52 Million
Q2 2018 Aug 14, 2018	BUY	$25.7 - $47.88 $899,500 - $1.68 Million	35,000 Added 24.14%	180,000 $6.07 Million
Q1 2018 May 14, 2018	BUY	$17.46 - $32.59 $2.53 Million - $4.73 Million	145,000 New	145,000 $3.92 Million

310

80M

256K

146K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.24B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.